Technavio analyzes that the Amlodipine Besylate Market is expected to grow at a CAGR of 3.3% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 196.4 million.There are various factors that contribute to the growth of the market. The prevalence of hypertension, a leading global health concern, is on the rise, resulting in an increased demand for effective treatment options. Amlodipine Besylate, a calcium channel blocker, is a popular choice among healthcare professionals due to its efficacy in managing hypertension. This medication, available in various formulations, offers patients a reliable solution to control their blood pressure levels and reduce the risk of cardiovascular complications. As the population ages and the incidence of hypertension continues to grow, the market for Amlodipine Besylate is expected to expand significantly.
Amlodipine besylate is a crucial medication for managing hypertension (high blood pressure), a silent condition that can pose significant risks to various organs, including the brain, heart, kidneys, and blood vessels. Untreated hypertension can lead to severe health complications, such as heart attack, heart failure, stroke, and kidney failure. Amlodipine, available in both benzoate and besylate forms, plays a vital role in preventing angina (chest pain) and aortic stenosis, conditions indicative of underlying heart problems. Despite feeling well, patients with hypertension must adhere to their medication regimen, as the condition often remains asymptomatic until it causes complications. Allergies to Amlodipine besylate may occur, and patients should report any adverse reactions to their healthcare provider.
Know which region is leading the market growth by requesting a sample report
Amlodipine Besylate Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
Amlodipine Besylate is a prescription medication used by healthcare providers to manage various cardiovascular conditions. Its mechanism of action involves relaxing the muscles in blood vessels, improving blood flow. Dosage forms include oral tablets, oral solution, and oral suspension. Brands like Katerzia, Norliqva, and Norvasc are available. Store at room temperature, avoid stomach pain, nausea, tiredness, sleepiness, edema, dizziness, flushing, decreased blood pressure, and hypotension. Contraindications include aortic stenosis, angina, heart attack, allergies to Amlodipine Benzoate or Amlodipine Besylate, and interaction with OTC medicines.
The Amlodipine Besylate market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or production of various drug forms, including generic and non-generic drugs. According to Technavio, the healthcare sector's market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several factors, such as the increasing elderly population. By 2050, approximately one-quarter of the US population and Europe's population ratio is predicted to be over 60 years old. This demographic shift will create a substantial demand for medications like Amlodipine Besylate, which is used to treat various cardiovascular conditions by relaxing blood vessels. The market offers various dosage forms, such as oral tablets and oral solutions, under brands like Katerzia, Norliqva, and Norvasc.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
